Currently holds positions in Baxalta Inc, Biomarin Pharmaceutical Inc, Carmax Inc and Aptinyx Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Chief Operating Officer, Executive Vice President | Baxalta Inc | None - |
Independent Director | Biomarin Pharmaceutical Inc | Sept. 28, 2017 - |
Independent Director | Carmax Inc | April 1, 2018 - |
Independent Director | Aptinyx Inc | May 1, 2018 - |
Chief Financial Officer, Corporate Vice President | Baxter International Inc | March 23, 2011 - Jan. 1, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2021-11-15 | 2021-11-12 |
Aptinyx Inc
(APTX)
|
B Purchase |
74,600
+51.6%
2.40179,040 USD |
74,600 +51.6% | 2.40 | 179,040 USD | |
2021-11-15 | 2021-11-11 |
Aptinyx Inc
(APTX)
|
B Purchase |
5,400
+3.9%
2.4012,960 USD |
5,400 +3.9% | 2.40 | 12,960 USD | |
2020-01-14 | 2020-01-10 |
Aptinyx Inc
(APTX)
|
B Purchase |
50,000
+56.1%
3.00150,000 USD |
50,000 +56.1% | 3.00 | 150,000 USD | |
2019-01-28 | 2019-01-25 |
Aptinyx Inc
(APTX)
|
B Purchase |
11,655
+31.1%
5.5464,569 USD |
11,655 +31.1% | 5.54 | 64,569 USD | |
2019-01-28 | 2019-01-24 |
Aptinyx Inc
(APTX)
|
B Purchase |
13,345
+55.4%
5.5273,664 USD |
13,345 +55.4% | 5.52 | 73,664 USD |